• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,471.95
    176.40 (+0.31%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,560.35(%)
  • Trent
    2,815.00 3,507.32(%)
  • Raymond
    1,024.00 869.05(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 521.75(%)
  • One 97
    1,829.50 1,759.05(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,673.50(%)
  • Britannia Inds.
    4,946.05 5,000.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Makers Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 366.0
  • ISIN : INE987A01010
177.97 -7 (-3.74%)
  • As on 11 Sep 2026 (EOD)

  • Today’s Low

    176.98

  • Today’s High

    191.00

  • Open

    188.45

  • Perv Close

    184.89

  • 52W Low

    150.00

  • 52W High

    236.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    105.01

  • Div & Yield %

    0.00

  • Book Value(₹)

    92.26

  • Debt-Equity Ratio

    -3.74

  • AGM Date

    10-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    105.01

  • RONW (%)

    -7.27

  • ROCE (%)

    -2.19

Score Board

  • Equity (₹ in Cr.)

    5.90

  • BV (₹)

    92.30

  • Sales( ₹ in Cr.)

    50.35

  • NP (in Cr.)

    -1.73

  • NP Var(%)

    70.0

  • Div%

    0.0

  • CPS (₹)

    1.80

  • EPS (₹)

    -2.90

  • Traded Value (₹ in Lakhs)

    105.41

  • 52 Week High

    236.00

  • 52 Week Low

    150.00

  • Price BSE

    179.0

  • Price NSE

    178.00

  • Market Capital( in Cr.)

    105.41

  • P/C Ratio

    98.10

  • P/E Ratio

    -61.10

  • Price Vs.BV

    -2.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 50.35 42.94 49.09 42.55 52.38 44.41
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 50.35 42.94 49.09 42.55 52.38 44.41
Other Income 0.59 10.92 1.15 1.14 0.85 0.41
Stock Adjustments 1.65 -3.93 3.06 -4.01 1.52 0.21
Total Income 52.59 49.93 53.30 39.68 54.75 45.03
EXPENDITURE :            
Raw Materials 27.67 19.41 32.74 23.28 29.44 22.67
Power and Fuel Cost 4.24 4.29 4.90 3.85 3.46 3.00
Employee Cost 9.69 9.05 9.17 7.45 8.16 7.63
Other Manufacturing Expenses 2.28 2.20 2.66 2.24 2.07 1.89
Selling and Administration Expenses 6.33 5.16 5.42 4.71 6.55 5.36
Miscellaneous Expenses 1.06 1.11 1.02 1.13 1.15 0.76
Employee Benefit Expenses 9.69 9.05 9.17 7.45 8.16 7.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 51.27 41.22 55.91 42.66 50.84 41.31
Operating Profit 1.32 8.72 -2.61 -3.00 3.90 3.72
Interest 0.53 0.94 1.63 1.38 1.68 1.60
Gross Profit 0.79 7.78 -4.24 -4.38 2.22 2.12
Depreciation 2.80 2.85 2.71 2.40 1.91 4.20
Profit Before Tax -2.01 4.93 -6.95 -6.78 0.31 -2.08
Current Tax 0.00 0.00 0.00 0.02 0.03 -0.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.29 0.29 0.00 -0.43 0.11 -0.29
Reported Net Profit -1.72 4.64 -6.95 -6.36 0.17 -1.62
Extraordinary Items 0.01 10.39 0.02 0.01 -0.04 0.17
Adjusted Net Profit -1.73 -5.75 -6.97 -6.37 0.21 -1.79
Adjustment below Net Profit 0.07 -0.04 0.08 -0.02 0.05 -0.05
P & L Balance brought forward 20.59 15.99 22.86 29.25 28.66 11.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 -0.36 -18.41
P & L Balance carried down 18.95 20.59 15.99 22.86 29.25 28.66
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.91 7.87 -11.78 -10.78 0.35 -3.29
Earnings Per Share(Adj)-Unit Curr -2.91 7.87 -11.78 -10.78 0.35 -3.16
Book Value 92.25 95.04 87.19 98.78 102.30 100.92
Book Value(Adj)-Unit Curr 92.25 95.04 87.19 98.78 102.30 96.83

Shareholding Pattern

  • Promoter Group

    61.27%

  • Public Share Holding

    38.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,106,990 52.66 3,106,990 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 508,366 8.62 508,366 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,615,356 61.27 3,615,356 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 22,797 0.39 22,797 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 22,897 0.39 22,897 2
2] Non Institution
Bodies Corporate 96,123 1.63 95,463 28
Clearing Members 1 0.00 1 1
Directors of their Relatives 21,741 0.37 21,081 1
Employees 100 0.00 0 1
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 40,081 0.68 36,361 50
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 60,493 1.03 60,493 96
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 553,413 9.38 553,413 14
Individuals holding nominal share capital up to Rs. 1 lakh 1,318,365 22.34 1,243,523 3,537
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 167,805 2.84 167,805 4
Sub Total 2,262,123 38.34 2,182,141 3,733
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,900,376 100.00 5,820,394 3,745

Company Background

Makers Laboratories LtdPharmaceuticals - Indian - Formulations

  • Makers Laboratories Ltd
  • BSE Code : 366.0
  • ISIN : INE987A01010

  • Incorporation Year

    1984

  • Registered Office

    54 D Kandivli Industrial Estat
    Charkop Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-2868 8544

  • FAX

    91-22-2868 8544

  • Chairman

    R K P Verma

  • Managing Director

  • Company Secretary

    Piyush Ajmera

  • Auditor

    NVC & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Makers Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Makers Labs. 178.65 50.94 50.35 -41.74 -2.54
Abbott India 25,272.60 7,217.19 6,929.05 33.26 43.78
Astrazeneca Phar 6,858.65 2,304.07 2,275.58 101.09 27.86
Glaxosmi. Pharma 2,840.80 3,932.76 3,790.20 45.38 58.17
Novartis India 2,425.05 393.10 354.33 61.24 15.94
Cipla 1,380.00 20,102.60 18,979.95 36.27 13.88
Bliss GVS Pharma 703.70 773.53 729.81 65.40 12.51
Amrutanjan Healt 493.80 520.13 502.55 26.45 24.16
Fermenta Biotec. 483.30 474.15 450.25 22.56 18.77
Guj. Themis Bio. 430.80 168.25 165.82 115.19 18.05
Ambalal Sarabhai 41.45 19.52 3.94 76.76 6.77